Company intelligence / Profile preview

메디젠휴먼케어

Seoul Songpa-gu, Seoul Special City, South Koreaaiexpo.co.kr ↗

Ownership: Private
Employees: ~45
Development stage: Other

Overview

메디젠휴먼케어는 개인별 질병 예측 및 맞춤형 건강관리 솔루션을 제공하는 유전체 분석 전문기업이다. 자체 개발한 빅데이터 기반의 정밀 유전체 분석 플랫폼(M-CHECK)과 비의료기관용 검사키트(MELTHY)를 통해 질병 위험도 예측 및 예방 중심의 헬스케어 서비스를 상용화하고 있다. 국내외 시장에서 사업을 확장 중이며 인도네시아 등 해외 합작법인 설립 사례가 있다. 신약개발보다는 진단·예방 중심으로 사업이 집중되어 있으며 임상시험 단계 신약 파이프라인은 없다[2][3][5].

Therapeutic areas: Other
Modalities: Diagnostic service (Genomic analysis)Platform-based healthcare solution (not a therapeutic drug developer)
Industry: Molecular Diagnostics

Partnerships

International expansion partners in Asia/Europe/US mentioned but not named specifically

Beyond the preview

Go deeper on 메디젠휴먼케어.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 메디젠휴먼케어.

Explore the full profile